Use of CRF1 receptor antagonists for preparing a drug for treating metabolic syndrome and/or obesity and/or dyslipoproteinemia

摘要

An object of the present invention is the use of a compound of formula (I):
or one of its pharmaceutically acceptable salts,
for the manufacture of a medicament for the prevention and/or the treatment of metabolic syndrome and/or obesity and/or dyslipoproteinemia.